Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2020

Details for Mechanism ID: 9303
Country/Region: Uganda
Year: 2015
Main Partner: U.S. Department of Defense
Main Partner Program: NA
Organizational Type: Other USG Agency
Funding Agency: USDOD
Total Funding: $683,266 Additional Pipeline Funding: $900,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $199,420
Care: Orphans and Vulnerable Children (HKID) $94,985
Care: TB/HIV (HVTB) $54,753
Care: Pediatric Care and Support (PDCS) $37,077
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $6,073
Testing: HIV Testing and Counseling (HVCT) $43,828
Sexual Prevention: Other Sexual Prevention (HVOP) $96,122
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $13,517
Treatment: Adult Treatment (HTXS) $113,761
Treatment: Pediatric Treatment (PDTX) $23,730
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 1,596
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 163
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 3,120
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 192
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 5,071
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 5,071
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 3,446
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 2,600
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 26,330
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 18,972
HTS_TST By Test Result: Negative 2016 49,423
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 51,348
HTS_TST Sum of Aggregated Age/Sex <15 2016 6,046
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 45,302
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 51,348
HTS_TST Sum of Test Result disaggregates 2016 51,348
HTS_TST_POS By Test Result: Positive 2016 1,925
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 916
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 1,782
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 201
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 201
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 166
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 35
PMTCT_ARV Sum of New and Current disaggregates 2016 201
PMTCT_STAT By: Known positives at entry 2016 166
PMTCT_STAT By: Number of new positives identified 2016 35
PMTCT_STAT Number of new ANC and L&D clients 2016 2,153
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 2,045
PMTCT_STAT Sum of Positives Status disaggregates 2016 201
PP_PREV Age/sex: 10-14 Female 2016 66
PP_PREV Age/sex: 10-14 Male 2016 55
PP_PREV Age/sex: 15-19 Female 2016 222
PP_PREV Age/sex: 15-19 Male 2016 525
PP_PREV Age/sex: 20-24 Female 2016 328
PP_PREV Age/sex: 20-24 Male 2016 842
PP_PREV Age/sex: 25-49 Female 2016 466
PP_PREV Age/sex: 25-49 Male 2016 940
PP_PREV Age/sex: 50+ Female 2016 32
PP_PREV Age/sex: 50+ Male 2016 40
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 3,516
PP_PREV Sum of Age/Sex disaggregates 2016 3,516
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 5,071
TX_CURR Aggregated Age/Sex: 15+ Female 2016 1,376
TX_CURR Aggregated Age/Sex: 15+ Male 2016 2,986
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 4,710
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 4,362
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 4,362
Cross Cutting Budget Categories and Known Amounts Total: $30,000
Condoms: Policy, Tools, and Services $5,000
Gender: Gender Equality $5,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Capacity building
Condoms: Commodities $10,000
Gender: Gender Based Violence (GBV) $10,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research